These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 18172298)

  • 41. Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues.
    Tu JJ; Rohan S; Kao J; Kitabayashi N; Mathew S; Chen YT
    Mod Pathol; 2007 Sep; 20(9):921-8. PubMed ID: 17632455
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical applications of novel ERG immunohistochemistry in prostate cancer diagnosis and management.
    Shah RB
    Adv Anat Pathol; 2013 Mar; 20(2):117-24. PubMed ID: 23399797
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Prostate cancer: the revolution of the fusion genes].
    Fernández-Serra A; Rubio-Briones J; García-Casado Z; Solsona E; López-Guerrero JA
    Actas Urol Esp; 2011; 35(7):420-8. PubMed ID: 21601955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer.
    Mehra R; Tomlins SA; Yu J; Cao X; Wang L; Menon A; Rubin MA; Pienta KJ; Shah RB; Chinnaiyan AM
    Cancer Res; 2008 May; 68(10):3584-90. PubMed ID: 18483239
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.
    Tomlins SA; Rhodes DR; Perner S; Dhanasekaran SM; Mehra R; Sun XW; Varambally S; Cao X; Tchinda J; Kuefer R; Lee C; Montie JE; Shah RB; Pienta KJ; Rubin MA; Chinnaiyan AM
    Science; 2005 Oct; 310(5748):644-8. PubMed ID: 16254181
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Frequent gene fusion in prostate cancer: clinical applications in diagnosis, prognosis and therapy].
    Schmidt F; Scheble V; Mertz K; Perner S; Rubin MA
    Dtsch Med Wochenschr; 2009 Jul; 134(28-29):1483-6. PubMed ID: 19572250
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming.
    Iljin K; Wolf M; Edgren H; Gupta S; Kilpinen S; Skotheim RI; Peltola M; Smit F; Verhaegh G; Schalken J; Nees M; Kallioniemi O
    Cancer Res; 2006 Nov; 66(21):10242-6. PubMed ID: 17079440
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel RNA hybridization method for the in situ detection of ETV1, ETV4, and ETV5 gene fusions in prostate cancer.
    Kunju LP; Carskadon S; Siddiqui J; Tomlins SA; Chinnaiyan AM; Palanisamy N
    Appl Immunohistochem Mol Morphol; 2014 Sep; 22(8):e32-40. PubMed ID: 25203299
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic interaction between Tmprss2-ERG gene fusion and Nkx3.1-loss does not enhance prostate tumorigenesis in mouse models.
    Linn DE; Bronson RT; Li Z
    PLoS One; 2015; 10(3):e0120628. PubMed ID: 25780911
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ETS gene fusions in prostate cancer.
    Clark JP; Cooper CS
    Nat Rev Urol; 2009 Aug; 6(8):429-39. PubMed ID: 19657377
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Concurrent TMPRSS2-ERG and SLC45A3-ERG rearrangements plus PTEN loss are not found in low grade prostate cancer and define an aggressive tumor subset.
    Hernández S; Font-Tello A; Juanpere N; de Muga S; Lorenzo M; Salido M; Fumadó L; Serrano L; Cecchini L; Serrano S; Lloreta J
    Prostate; 2016 Jun; 76(9):854-65. PubMed ID: 26959281
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular profiling of ETS gene rearrangements in patients with prostate cancer registered in REDEEM clinical trial.
    Palanisamy N; Tsodikov A; Yan W; Suleman K; Rittmaster R; Lucia SM; Chinnaiyan AM; Fleshner N; Kunju LP
    Urol Oncol; 2015 Mar; 33(3):108.e5-13. PubMed ID: 25175425
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer.
    Hessels D; Smit FP; Verhaegh GW; Witjes JA; Cornel EB; Schalken JA
    Clin Cancer Res; 2007 Sep; 13(17):5103-8. PubMed ID: 17785564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Etv5, an ETS transcription factor, is expressed in granulosa and cumulus cells and serves as a transcriptional regulator of the cyclooxygenase-2.
    Eo J; Han K; M Murphy K; Song H; Lim HJ
    J Endocrinol; 2008 Aug; 198(2):281-90. PubMed ID: 18492810
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Whole-transcriptome analysis reveals established and novel associations with TMPRSS2:ERG fusion in prostate cancer.
    Chow A; Amemiya Y; Sugar L; Nam R; Seth A
    Anticancer Res; 2012 Sep; 32(9):3629-41. PubMed ID: 22993300
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence of recurrent gene fusions in common epithelial tumors.
    Kumar-Sinha C; Tomlins SA; Chinnaiyan AM
    Trends Mol Med; 2006 Nov; 12(11):529-36. PubMed ID: 17011825
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic, Environmental, and Nuclear Factors Governing Genomic Rearrangements.
    Ramanand SG; Mani RS
    Adv Exp Med Biol; 2019; 1210():57-66. PubMed ID: 31900904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bioinformatics approach leads to the discovery of the TMPRSS2:ETS gene fusion in prostate cancer.
    Rubin MA; Chinnaiyan AM
    Lab Invest; 2006 Nov; 86(11):1099-102. PubMed ID: 16983328
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of TMPRSS2-ETS fusions by a multiprobe fluorescence in situ hybridization assay for the early diagnosis of prostate cancer: a pilot study.
    Sun QP; Li LY; Chen Z; Pang J; Yang WJ; Zhou XF; Qiu JG; Su ZL; He D; Gao X
    J Mol Diagn; 2010 Sep; 12(5):718-24. PubMed ID: 20616363
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TMPRSS2-ERG gene fusion and clinicopathologic characteristics of Korean prostate cancer patients.
    Lee K; Chae JY; Kwak C; Ku JH; Moon KC
    Urology; 2010 Nov; 76(5):1268.e7-13. PubMed ID: 20800881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.